Log in
Enquire now
‌

US Patent 10369197 Use of CD24 for lowering low-density lipoprotein cholesterol levels

Patent 10369197 was granted and assigned to OncoImmune on August, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The present invention relates to the use of a CD24 protein for lowering low-density lipoprotein cholesterol levels, treating and preventing atherosclerosis, and for reducing risk of cardiovascular disease.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10369197 Use of CD24 for lowering low-density lipoprotein cholesterol levels

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo